| abstract |
The present invention relates in part to immunostimulatory nucleic acids linked to a lipophilic group. It has been deiscovered that specific immunostimulatory nucleic acids linked to lipophilic groups have enhanced activity, whereas the linkage of lipophilic groups to other immunostimulatory nucleic acids has minimal effect on the immunostimulatory capability of the molecule. |